The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Janssen; Merck; Merck KGaA; Sanofi
Speakers' Bureau - Janssen
Patients with EGFR mutant (m) MET-altered NSCLC receiving tepotinib with an EGFR tyrosine kinase inhibitor (TKI): A case series.
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ArriVent Biopharma; AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Novartis; Sensei Biotherapeutics; Spectrum Pharmaceuticals
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Spectrum Pharmaceuticals
 
Anna Eisert
Consulting or Advisory Role - Amgen; Merck KGaA
Speakers' Bureau - Amgen; Merck KGaA
 
Te-Chun Hsia
No Relationships to Disclose
 
Nirmal Vivek Raut
No Relationships to Disclose
 
Azura Ahmad
Honoraria - Amgen; MSD; Novartis; Roche; Scigen
 
Oscar Siu Hong Chan
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Takeda
Consulting or Advisory Role - Merck KGaA; Pfizer; Takeda
 
Charlotte De Bondt
No Relationships to Disclose
 
David Farrugia
Honoraria - Amgen; Bristol Myers Squibb Foundation; Merck KGaA
 
Patrizia Froesch
Consulting or Advisory Role - Janssen Oncology; Lilly; Novartis; Pfizer; Roche; Sanofi; Takeda
 
Maria González-Cao
Honoraria - BeiGene Beijing; BMS Spain; MSD Oncology; Pierre Fabre; Sanofi
Speakers' Bureau - BMS Spain; MSD Oncology
Research Funding - AstraZeneca; Roche
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology
 
Lizza Hendriks
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech; Roche/Genentech (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
Speakers' Bureau - AstraZeneca (Inst); Bayer (Inst); Benecke; high5oncology (Inst); Lilly (Inst); Medtalks; MSD (Inst); Takeda (Inst); VJOncology
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Other Relationship - Abbvie (Inst); AstraZeneca; AstraZeneca (Inst); BluPrint Oncology (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck Serono (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Maximilian J. Hochmair
Other Relationship - AstraZeneca; Boehringer Ingelheim; MSD; Roche; Takeda
 
Julien Mazieres
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Pharmaceutical; Merck KGaA; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Roche/Genentech
 
Hazel O’Sullivan
Honoraria - Amgen
Travel, Accommodations, Expenses - Takeda
 
Jens Samol
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol Myers Squibb Foundation; Eisai; Ipsen; MSD; Roche; Taiho Pharmaceutical
 
Anthonie J. van der Wekken
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen; Lilly O.; Merck KGaA; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim; Pfizer; Roche; Takeda
 
Tsung-Ying Yang
No Relationships to Disclose
 
Kirti Joshi
Employment - ICON Clinical Research
 
Soetkin Vlassak
Employment - Merck KGaA
 
Gee-Chen Chang
No Relationships to Disclose